Share Price and Basic Stock Data
Last Updated: March 7, 2025, 8:31 pm
PEG Ratio | 0.50 |
---|
Competitors of Fluidomat Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Miven Machine Tools Ltd | 28.6 Cr. | 95.0 | 126/67.0 | 17.8 | 0.00 % | % | % | 10.0 | |
Incon Engineers Ltd | 5.75 Cr. | 13.3 | 24.8/11.5 | 0.44 | 0.00 % | 72.7 % | 162 % | 10.0 | |
Hittco Tools Ltd | 7.39 Cr. | 12.0 | 16.0/9.53 | 4.30 | 0.00 % | 7.27 % | 5.66 % | 10.0 | |
Harshil Agrotech Ltd | 384 Cr. | 5.40 | 19.3/0.83 | 34.2 | 0.86 | 0.00 % | 16.4 % | 13.5 % | 1.00 |
Gujarat Toolroom Ltd | 252 Cr. | 1.81 | 7.66/1.66 | 2.40 | 1.24 | 9.21 % | 179 % | 170 % | 1.00 |
Industry Average | 3,174.68 Cr | 424.23 | 42.80 | 120.55 | 0.52% | 29.10% | 26.17% | 6.30 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 8.69 | 11.11 | 8.91 | 13.03 | 9.92 | 14.29 | 12.56 | 14.65 | 12.63 | 15.65 | 15.59 | 19.00 | 16.64 |
Expenses | 7.05 | 8.88 | 6.99 | 9.15 | 7.83 | 9.84 | 9.19 | 10.44 | 9.53 | 11.45 | 10.39 | 11.32 | 10.64 |
Operating Profit | 1.64 | 2.23 | 1.92 | 3.88 | 2.09 | 4.45 | 3.37 | 4.21 | 3.10 | 4.20 | 5.20 | 7.68 | 6.00 |
OPM % | 18.87% | 20.07% | 21.55% | 29.78% | 21.07% | 31.14% | 26.83% | 28.74% | 24.54% | 26.84% | 33.35% | 40.42% | 36.06% |
Other Income | 0.47 | 0.41 | 0.35 | 0.39 | 0.36 | 0.17 | 0.59 | 0.70 | 0.58 | 1.58 | 0.67 | 0.76 | 1.33 |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.18 | 0.17 | 0.20 | 0.20 | 0.20 | 0.14 | 0.19 | 0.19 | 0.18 | 0.20 | 0.21 | 0.23 | 0.23 |
Profit before tax | 1.93 | 2.47 | 2.07 | 4.07 | 2.25 | 4.48 | 3.77 | 4.72 | 3.50 | 5.58 | 5.66 | 8.21 | 7.10 |
Tax % | 27.46% | 27.94% | 25.12% | 25.06% | 24.00% | 26.34% | 26.53% | 25.21% | 25.43% | 25.63% | 25.09% | 24.73% | 23.66% |
Net Profit | 1.41 | 1.79 | 1.55 | 3.05 | 1.71 | 3.30 | 2.77 | 3.52 | 2.61 | 4.15 | 4.24 | 6.17 | 5.42 |
EPS in Rs | 2.86 | 3.63 | 3.15 | 6.19 | 3.47 | 6.70 | 5.62 | 7.14 | 5.30 | 8.42 | 8.61 | 12.52 | 11.00 |
Last Updated: March 4, 2025, 12:18 pm
Below is a detailed analysis of the quarterly data for Fluidomat Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹16.64 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Sep 2024) to ₹16.64 Cr., marking a decrease of 2.36 Cr..
- For Expenses, as of Dec 2024, the value is ₹10.64 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.32 Cr. (Sep 2024) to ₹10.64 Cr., marking a decrease of 0.68 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.68 Cr. (Sep 2024) to ₹6.00 Cr., marking a decrease of 1.68 Cr..
- For OPM %, as of Dec 2024, the value is 36.06%. The value appears to be declining and may need further review. It has decreased from 40.42% (Sep 2024) to 36.06%, marking a decrease of 4.36%.
- For Other Income, as of Dec 2024, the value is ₹1.33 Cr.. The value appears strong and on an upward trend. It has increased from 0.76 Cr. (Sep 2024) to ₹1.33 Cr., marking an increase of ₹0.57 Cr..
- For Interest, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹0.23 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.23 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹7.10 Cr.. The value appears to be declining and may need further review. It has decreased from 8.21 Cr. (Sep 2024) to ₹7.10 Cr., marking a decrease of 1.11 Cr..
- For Tax %, as of Dec 2024, the value is 23.66%. The value appears to be improving (decreasing) as expected. It has decreased from 24.73% (Sep 2024) to 23.66%, marking a decrease of 1.07%.
- For Net Profit, as of Dec 2024, the value is ₹5.42 Cr.. The value appears to be declining and may need further review. It has decreased from 6.17 Cr. (Sep 2024) to ₹5.42 Cr., marking a decrease of 0.75 Cr..
- For EPS in Rs, as of Dec 2024, the value is 11.00. The value appears to be declining and may need further review. It has decreased from ₹12.52 (Sep 2024) to 11.00, marking a decrease of ₹1.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 1:07 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 29 | 28 | 28 | 27 | 26 | 24 | 27 | 25 | 28 | 33 | 45 | 55 | 67 |
Expenses | 21 | 20 | 20 | 21 | 22 | 21 | 24 | 22 | 23 | 26 | 33 | 40 | 44 |
Operating Profit | 8 | 8 | 8 | 6 | 4 | 3 | 3 | 3 | 5 | 6 | 12 | 15 | 23 |
OPM % | 27% | 30% | 28% | 21% | 15% | 12% | 11% | 13% | 17% | 19% | 27% | 27% | 35% |
Other Income | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 3 | 4 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Profit before tax | 8 | 8 | 8 | 6 | 4 | 3 | 3 | 4 | 5 | 7 | 13 | 18 | 27 |
Tax % | 33% | 33% | 33% | 33% | 34% | 26% | 28% | 25% | 26% | 26% | 25% | 26% | |
Net Profit | 5 | 6 | 5 | 4 | 3 | 2 | 2 | 3 | 4 | 5 | 10 | 13 | 20 |
EPS in Rs | 10.41 | 11.57 | 10.82 | 8.06 | 5.58 | 4.73 | 4.85 | 6.49 | 8.08 | 11.14 | 19.53 | 26.49 | 40.55 |
Dividend Payout % | 24% | 24% | 25% | 31% | 31% | 37% | 41% | 35% | 40% | 31% | 23% | 21% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 20.00% | -16.67% | -20.00% | -25.00% | -33.33% | 0.00% | 50.00% | 33.33% | 25.00% | 100.00% | 30.00% |
Change in YoY Net Profit Growth (%) | 0.00% | -36.67% | -3.33% | -5.00% | -8.33% | 33.33% | 50.00% | -16.67% | -8.33% | 75.00% | -70.00% |
Fluidomat Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 15% |
3 Years: | 25% |
TTM: | 24% |
Compounded Profit Growth | |
---|---|
10 Years: | 9% |
5 Years: | 40% |
3 Years: | 49% |
TTM: | 64% |
Stock Price CAGR | |
---|---|
10 Years: | 12% |
5 Years: | 56% |
3 Years: | 80% |
1 Year: | 34% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 17% |
3 Years: | 20% |
Last Year: | 24% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 3:35 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Reserves | 12 | 16 | 20 | 22 | 25 | 26 | 27 | 28 | 32 | 36 | 44 | 56 | 65 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Other Liabilities | 7 | 7 | 7 | 7 | 6 | 7 | 7 | 7 | 8 | 10 | 11 | 10 | 16 |
Total Liabilities | 24 | 28 | 32 | 34 | 36 | 38 | 40 | 41 | 45 | 51 | 60 | 71 | 86 |
Fixed Assets | 6 | 7 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 8 | 7 | 8 | 9 |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Investments | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 3 | 5 | 8 |
Other Assets | 17 | 21 | 24 | 26 | 28 | 29 | 32 | 33 | 37 | 41 | 50 | 58 | 68 |
Total Assets | 24 | 28 | 32 | 34 | 36 | 38 | 40 | 41 | 45 | 51 | 60 | 71 | 86 |
Below is a detailed analysis of the balance sheet data for Fluidomat Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹5.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹65.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹56.00 Cr. (Mar 2024) to ₹65.00 Cr., marking an increase of 9.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹10.00 Cr. (Mar 2024) to ₹16.00 Cr., marking an increase of 6.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹86.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹71.00 Cr. (Mar 2024) to ₹86.00 Cr., marking an increase of 15.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹9.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹8.00 Cr. (Mar 2024) to ₹9.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹1.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹0.00 Cr. (Mar 2024) to ₹1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2024, the value is ₹8.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹5.00 Cr. (Mar 2024) to ₹8.00 Cr., marking an increase of 3.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹68.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹58.00 Cr. (Mar 2024) to ₹68.00 Cr., marking an increase of 10.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹86.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹71.00 Cr. (Mar 2024) to ₹86.00 Cr., marking an increase of 15.00 Cr..
Notably, the Reserves (₹65.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 8.00 | 8.00 | 8.00 | 6.00 | 4.00 | 3.00 | 3.00 | 2.00 | 5.00 | 6.00 | 12.00 | 15.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 99 | 88 | 103 | 164 | 122 | 160 | 139 | 118 | 117 | 120 | 110 | 90 |
Inventory Days | 87 | 155 | 212 | 223 | 165 | 181 | 142 | 214 | 189 | 141 | 141 | 113 |
Days Payable | 51 | 72 | 89 | 75 | 58 | 92 | 79 | 118 | 123 | 137 | 91 | 70 |
Cash Conversion Cycle | 134 | 170 | 225 | 312 | 228 | 249 | 202 | 214 | 183 | 124 | 159 | 132 |
Working Capital Days | 70 | 65 | 96 | 164 | 139 | 185 | 169 | 183 | 159 | 146 | 90 | 150 |
ROCE % | 51% | 45% | 35% | 23% | 15% | 10% | 11% | 13% | 15% | 18% | 29% | 32% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 19.48 | 11.65 | 8.93 | 6.05 |
Diluted EPS (Rs.) | 19.48 | 11.65 | 8.93 | 6.05 |
Cash EPS (Rs.) | 21.01 | 12.47 | 9.39 | 7.82 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 99.84 | 83.86 | 75.45 | 66.52 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 99.84 | 83.86 | 75.45 | 66.52 |
Revenue From Operations / Share (Rs.) | 93.68 | 69.15 | 57.38 | 51.74 |
PBDIT / Share (Rs.) | 27.62 | 15.73 | 12.30 | 10.01 |
PBIT / Share (Rs.) | 26.12 | 14.38 | 11.00 | 8.66 |
PBT / Share (Rs.) | 26.12 | 15.05 | 10.95 | 8.65 |
Net Profit / Share (Rs.) | 19.51 | 11.12 | 8.09 | 6.47 |
NP After MI And SOA / Share (Rs.) | 19.51 | 11.12 | 8.09 | 6.47 |
PBDIT Margin (%) | 29.48 | 22.75 | 21.43 | 19.33 |
PBIT Margin (%) | 27.88 | 20.79 | 19.16 | 16.74 |
PBT Margin (%) | 27.88 | 21.76 | 19.08 | 16.72 |
Net Profit Margin (%) | 20.82 | 16.07 | 14.09 | 12.51 |
NP After MI And SOA Margin (%) | 20.82 | 16.07 | 14.09 | 12.51 |
Return on Networth / Equity (%) | 19.53 | 13.25 | 10.72 | 9.73 |
Return on Capital Employeed (%) | 25.54 | 16.69 | 14.21 | 12.66 |
Return On Assets (%) | 16.03 | 10.69 | 8.87 | 7.77 |
Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.02 |
Asset Turnover Ratio (%) | 0.83 | 0.70 | 0.65 | 0.00 |
Current Ratio (X) | 2.74 | 2.86 | 3.06 | 2.79 |
Quick Ratio (X) | 2.07 | 2.32 | 2.25 | 2.05 |
Inventory Turnover Ratio (X) | 3.10 | 2.36 | 1.90 | 0.00 |
Dividend Payout Ratio (NP) (%) | 17.94 | 29.23 | 0.00 | 30.88 |
Dividend Payout Ratio (CP) (%) | 16.66 | 26.05 | 0.00 | 25.59 |
Earning Retention Ratio (%) | 82.06 | 70.77 | 0.00 | 69.12 |
Cash Earning Retention Ratio (%) | 83.34 | 73.95 | 0.00 | 74.41 |
Interest Coverage Ratio (X) | 136101.00 | 2500.90 | 268.10 | 704.26 |
Interest Coverage Ratio (Post Tax) (X) | 96208.00 | 1660.16 | 177.38 | 456.79 |
Enterprise Value (Cr.) | 101.07 | 84.85 | 41.93 | 31.44 |
EV / Net Operating Revenue (X) | 2.19 | 2.49 | 1.48 | 1.23 |
EV / EBITDA (X) | 7.43 | 10.94 | 6.92 | 6.38 |
MarketCap / Net Operating Revenue (X) | 2.24 | 2.55 | 1.52 | 1.23 |
Retention Ratios (%) | 82.05 | 70.76 | 0.00 | 69.11 |
Price / BV (X) | 2.10 | 2.10 | 1.15 | 0.95 |
Price / Net Operating Revenue (X) | 2.24 | 2.55 | 1.52 | 1.23 |
EarningsYield | 0.09 | 0.06 | 0.09 | 0.10 |
After reviewing the key financial ratios for Fluidomat Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 23, the value is 19.48. This value is within the healthy range. It has increased from 11.65 (Mar 22) to 19.48, marking an increase of 7.83.
- For Diluted EPS (Rs.), as of Mar 23, the value is 19.48. This value is within the healthy range. It has increased from 11.65 (Mar 22) to 19.48, marking an increase of 7.83.
- For Cash EPS (Rs.), as of Mar 23, the value is 21.01. This value is within the healthy range. It has increased from 12.47 (Mar 22) to 21.01, marking an increase of 8.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 99.84. It has increased from 83.86 (Mar 22) to 99.84, marking an increase of 15.98.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 99.84. It has increased from 83.86 (Mar 22) to 99.84, marking an increase of 15.98.
- For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 93.68. It has increased from 69.15 (Mar 22) to 93.68, marking an increase of 24.53.
- For PBDIT / Share (Rs.), as of Mar 23, the value is 27.62. This value is within the healthy range. It has increased from 15.73 (Mar 22) to 27.62, marking an increase of 11.89.
- For PBIT / Share (Rs.), as of Mar 23, the value is 26.12. This value is within the healthy range. It has increased from 14.38 (Mar 22) to 26.12, marking an increase of 11.74.
- For PBT / Share (Rs.), as of Mar 23, the value is 26.12. This value is within the healthy range. It has increased from 15.05 (Mar 22) to 26.12, marking an increase of 11.07.
- For Net Profit / Share (Rs.), as of Mar 23, the value is 19.51. This value is within the healthy range. It has increased from 11.12 (Mar 22) to 19.51, marking an increase of 8.39.
- For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is 19.51. This value is within the healthy range. It has increased from 11.12 (Mar 22) to 19.51, marking an increase of 8.39.
- For PBDIT Margin (%), as of Mar 23, the value is 29.48. This value is within the healthy range. It has increased from 22.75 (Mar 22) to 29.48, marking an increase of 6.73.
- For PBIT Margin (%), as of Mar 23, the value is 27.88. This value exceeds the healthy maximum of 20. It has increased from 20.79 (Mar 22) to 27.88, marking an increase of 7.09.
- For PBT Margin (%), as of Mar 23, the value is 27.88. This value is within the healthy range. It has increased from 21.76 (Mar 22) to 27.88, marking an increase of 6.12.
- For Net Profit Margin (%), as of Mar 23, the value is 20.82. This value exceeds the healthy maximum of 10. It has increased from 16.07 (Mar 22) to 20.82, marking an increase of 4.75.
- For NP After MI And SOA Margin (%), as of Mar 23, the value is 20.82. This value exceeds the healthy maximum of 20. It has increased from 16.07 (Mar 22) to 20.82, marking an increase of 4.75.
- For Return on Networth / Equity (%), as of Mar 23, the value is 19.53. This value is within the healthy range. It has increased from 13.25 (Mar 22) to 19.53, marking an increase of 6.28.
- For Return on Capital Employeed (%), as of Mar 23, the value is 25.54. This value is within the healthy range. It has increased from 16.69 (Mar 22) to 25.54, marking an increase of 8.85.
- For Return On Assets (%), as of Mar 23, the value is 16.03. This value is within the healthy range. It has increased from 10.69 (Mar 22) to 16.03, marking an increase of 5.34.
- For Total Debt / Equity (X), as of Mar 23, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 23, the value is 0.83. It has increased from 0.70 (Mar 22) to 0.83, marking an increase of 0.13.
- For Current Ratio (X), as of Mar 23, the value is 2.74. This value is within the healthy range. It has decreased from 2.86 (Mar 22) to 2.74, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 23, the value is 2.07. This value exceeds the healthy maximum of 2. It has decreased from 2.32 (Mar 22) to 2.07, marking a decrease of 0.25.
- For Inventory Turnover Ratio (X), as of Mar 23, the value is 3.10. This value is below the healthy minimum of 4. It has increased from 2.36 (Mar 22) to 3.10, marking an increase of 0.74.
- For Dividend Payout Ratio (NP) (%), as of Mar 23, the value is 17.94. This value is below the healthy minimum of 20. It has decreased from 29.23 (Mar 22) to 17.94, marking a decrease of 11.29.
- For Dividend Payout Ratio (CP) (%), as of Mar 23, the value is 16.66. This value is below the healthy minimum of 20. It has decreased from 26.05 (Mar 22) to 16.66, marking a decrease of 9.39.
- For Earning Retention Ratio (%), as of Mar 23, the value is 82.06. This value exceeds the healthy maximum of 70. It has increased from 70.77 (Mar 22) to 82.06, marking an increase of 11.29.
- For Cash Earning Retention Ratio (%), as of Mar 23, the value is 83.34. This value exceeds the healthy maximum of 70. It has increased from 73.95 (Mar 22) to 83.34, marking an increase of 9.39.
- For Interest Coverage Ratio (X), as of Mar 23, the value is 136,101.00. This value is within the healthy range. It has increased from 2,500.90 (Mar 22) to 136,101.00, marking an increase of 133,600.10.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 96,208.00. This value is within the healthy range. It has increased from 1,660.16 (Mar 22) to 96,208.00, marking an increase of 94,547.84.
- For Enterprise Value (Cr.), as of Mar 23, the value is 101.07. It has increased from 84.85 (Mar 22) to 101.07, marking an increase of 16.22.
- For EV / Net Operating Revenue (X), as of Mar 23, the value is 2.19. This value is within the healthy range. It has decreased from 2.49 (Mar 22) to 2.19, marking a decrease of 0.30.
- For EV / EBITDA (X), as of Mar 23, the value is 7.43. This value is within the healthy range. It has decreased from 10.94 (Mar 22) to 7.43, marking a decrease of 3.51.
- For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 2.24. This value is within the healthy range. It has decreased from 2.55 (Mar 22) to 2.24, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 23, the value is 82.05. This value exceeds the healthy maximum of 70. It has increased from 70.76 (Mar 22) to 82.05, marking an increase of 11.29.
- For Price / BV (X), as of Mar 23, the value is 2.10. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 2.10.
- For Price / Net Operating Revenue (X), as of Mar 23, the value is 2.24. This value is within the healthy range. It has decreased from 2.55 (Mar 22) to 2.24, marking a decrease of 0.31.
- For EarningsYield, as of Mar 23, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 22) to 0.09, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fluidomat Ltd:
- Net Profit Margin: 20.82%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 25.54% (Industry Average ROCE: 29.1%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.53% (Industry Average ROE: 26.17%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 96208
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 19.1 (Industry average Stock P/E: 42.8)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.82%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Engineering - General | 117, 1st Floor, Navneet Darshan, Indore Madhya Pradesh 452018 | info@fluidomat.com http://www.fluidomat.com |
Management | |
---|---|
Name | Position Held |
Mr. Ashok Jain | Chairman & Managing Director |
Mrs. Radhica Sharma | Deputy Managing Director |
Mr. Kunal Jain | Executive Director |
Mr. Ashok Kumar Patni | Independent Director |
Mr. Sharad Panot | Independent Director |
Mr. Samyak Modi | Independent Director |
FAQ
What is the latest intrinsic value of Fluidomat Ltd?
The latest intrinsic value of Fluidomat Ltd as on 09 March 2025 is ₹517.88, which is 32.92% lower than the current market price of 772.00, indicating the stock is overvalued by 32.92%. The intrinsic value of Fluidomat Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹381 Cr. and recorded a high/low of ₹1,181/457 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹65 Cr and total liabilities of ₹86 Cr.
What is the Market Cap of Fluidomat Ltd?
The Market Cap of Fluidomat Ltd is 381 Cr..
What is the current Stock Price of Fluidomat Ltd as on 09 March 2025?
The current stock price of Fluidomat Ltd as on 09 March 2025 is ₹772.
What is the High / Low of Fluidomat Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Fluidomat Ltd stocks is ₹1,181/457.
What is the Stock P/E of Fluidomat Ltd?
The Stock P/E of Fluidomat Ltd is 19.1.
What is the Book Value of Fluidomat Ltd?
The Book Value of Fluidomat Ltd is 142.
What is the Dividend Yield of Fluidomat Ltd?
The Dividend Yield of Fluidomat Ltd is 0.71 %.
What is the ROCE of Fluidomat Ltd?
The ROCE of Fluidomat Ltd is 32.0 %.
What is the ROE of Fluidomat Ltd?
The ROE of Fluidomat Ltd is 23.7 %.
What is the Face Value of Fluidomat Ltd?
The Face Value of Fluidomat Ltd is 10.0.